RNR Healthcare, Led by CEO Vicky Ramancha, to Open Pharmaceutical Trading Entity in the US

Published October 9, 2023

New York, New York--(Newsfile Corp. - October 9, 2023) - RNR Healthcare CEO Vicky Ramancha has announced to be entering USA market with pharmaceutical licensed trading entity. RNR Healthcare is currently under process of acquiring pharmaceutical license and will be opening up offices and operational units in the US to be estimated in the first quarter of 2024.

Cannot view this image? Visit: https://images.newsfilecorp.com/files/10000/183339_8d8a24ab748119e5_001.jpg
Vicky Ramancha, Chief Executive Officer of RNR Healthcare

To view an enhanced version of this graphic, please visit:

Vicky Ramancha, Chief Executive Officer of RNR Healthcare, has announced that the firm is preparing market entry strategy and operations for the US market as soon as pharmaceutical license will be granted.

RNR Healthcare is estimating to be fully operational in the US market by the 2nd quarter of 2024.

About RNR Healthcare

RNR Healthcare is a global pharmaceutical and medical equipment trading company specializing in sourcing and procuring in high demand pharmaceutical and medical products.

Vicky Ramancha

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/183339